Home » Topics » Regulatory

Regulatory
RSS

Rebif launched in Canada: first drug to delay disease progression in remitting-relapsing MS

Feb. 20, 1998

New octreotide formulation launched in Italy

Feb. 20, 1998

FDA approves new indication for pilocarpine

Feb. 19, 1998

New once-daily antihypertensive combination available in U.S.

Feb. 18, 1998

New formulation of FK-506 demonstrates superior efficacy

Feb. 17, 1998

IND approved for new formulation of lidocaine

Feb. 17, 1998

CellCept evaluated in the clinic for another new indication

Feb. 17, 1998

Micronized fenofibrate receives FDA approval

Feb. 16, 1998

FDA approves CellCept for new indication

Feb. 16, 1998

FDA approves new dosage strength of Lodine XL

Feb. 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...